Alpha Profiles · Company Profile

Chemomab Therapeutics Ltd.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/chemomab-therapeutics-ltd

Entity: Public listing published
Primary listing: NASDAQ: CMMB
Verification: Partially verified
Last reviewed: 2026-09-12T21:32:35.041126+00:00

Overview

Alpha's canonical identity and public leadership record for Chemomab Therapeutics Ltd..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

4 public records

Adi Mor

Director, Chief Scientific Officer

State: confirmed
Effective: From Mar 20, 2023
Confidence: 94%
Evidence: CMMB 10-K executive officersMar 20, 2023

Dale Pfost

Chairman of the Board, Chief Executive Officer

State: confirmed
Effective: From Mar 20, 2023
Confidence: 94%
Evidence: CMMB 10-K executive officersMar 20, 2023

Donald Marvin

Chief Financial Officer, Executive Vice President and Chief Operating Officer

State: confirmed
Effective: From Mar 20, 2023
Confidence: 94%
Evidence: CMMB 10-K executive officersMar 20, 2023

Matthew Frankel

Chief Medical Officer

State: confirmed
Effective: From Mar 20, 2023
Confidence: 94%
Evidence: CMMB 10-K executive officersMar 20, 2023

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 12, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.